Melqart Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Melqart Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-17,900	Closed	-$1.07M	–	55
2019 Q4	$1.07M	Buy	+17,900	New	+$672K	0.09%	39

Melqart Asset Management's BOLD Position: Q1 2020 in Review

Melqart Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 17,900 shares — an estimated $1.07M sold.

Melqart Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $1.07M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Melqart Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Melqart Asset Management sold 17,900 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.07M.
Melqart Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Melqart Asset Management's Audentes Therapeutics, Inc position peaked at $1.07M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Melqart Asset Management's 13F filing for Q1 2020, filed 15 May 2020.